{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:17:07Z","timestamp":1792120627079,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.euroneuro.2020.04.009","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T18:08:03Z","timestamp":1592676483000},"page":"244-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Experiences with medical cannabis in the treatment of veterans with PTSD: Results from a focus group discussion"],"prefix":"10.1016","volume":"36","author":[{"given":"Erwin","family":"Krediet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie GA","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eibert R","family":"Heerdink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toine CG","family":"Egberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vermetten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.euroneuro.2020.04.009_bib0001","first-page":"280","article-title":"A new ESI-LC\/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis","volume":"8","author":"Berman","year":"2018","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.euroneuro.2020.04.009_bib0002","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S2215-0366(19)30401-8","article-title":"Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis","volume":"6","author":"Black","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0003","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/a0026621","article-title":"Prospective investigation of the impact of cannabis use disorders on posttraumatic stress disorder symptoms among veterans in residential treatment","volume":"5","author":"Bonn-Miller","year":"2013","journal-title":"Psychol. Trauma Theory Res. Pract. Policy"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0004","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jts.20243","article-title":"Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event-exposed marijuana users","volume":"20","author":"Bonn-Miller","year":"2007","journal-title":"J. Trauma. Stress"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0005","first-page":"3195","article-title":"Pharmacological evidence of medicinal cannabis in oncology: a systematic review","volume":"27","author":"Brown","year":"2019","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0006","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/2167702615598756","article-title":"The lingering impact of resolved PTSD on subsequent functioning","volume":"4","author":"Bryant","year":"2016","journal-title":"Clin. Psychol. Sci."},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0007","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/JCP.0000000000000180","article-title":"Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder\u2013related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation","volume":"34","author":"Cameron","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0008","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1017\/S003329171700349X","article-title":"Comparative efficacy and acceptability of pharmacological treatments for post-traumatic stress disorder in adults: a network meta-analysis","volume":"48","author":"Cipriani","year":"2018","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0009","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hup.1048","article-title":"Cannabis and anxiety: a critical review of the evidence","volume":"24","author":"Crippa","year":"2009","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.euroneuro.2020.04.009_bib43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.addbeh.2017.08.010","article-title":"Recent cannabis use among Veterans in the United States: Results from a national sample","volume":"76","author":"Davis","year":"2018","journal-title":"Addict Behav"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S2215-0366(14)00117-5","article-title":". Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study","volume":"2","author":"Di Forti","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0011","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2215-0366(19)30048-3","article-title":". The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study","volume":"6","author":"Di Forti","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0012","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.biopsych.2016.01.004","article-title":"Changes in cannabis potency over the Last 2 decades (1995\u20132014): analysis of current data in the United States","volume":"79","author":"ElSohly","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0013","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/0269881112460109","article-title":"Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment","volume":"27","author":"Englund","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0014","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1755-5949.2008.00071.x","article-title":"The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD)","volume":"15","author":"Fraser","year":"2009","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0015","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.neubiorev.2019.09.036","article-title":"How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review","volume":"107","author":"Freeman","year":"2019","journal-title":"Neurosci. Biobehav. Rev"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0016","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/gbb.12349","article-title":"Neurobiology of comorbid post-traumatic stress disorder and alcohol-use disorder: neurobiology of comorbid PTSD and AUD","volume":"16","author":"Gilpin","year":"2017","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0017","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/02791072.2013.873843","article-title":"PTSD symptom reports of patients evaluated for the New Mexico medical cannabis program","volume":"46","author":"Greer","year":"2014","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0018","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0019","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1176\/appi.ajp.2015.15070907","article-title":"Prevalence and correlates of DSM-5 cannabis use disorder, 2012\u20132013: findings from the national epidemiologic survey on alcohol and related conditions\u2013III","volume":"173","author":"Hasin","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0020","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/npp.2017.162","article-title":"Integrating endocannabinoid signaling and cannabinoids into the biology and treatment of posttraumatic stress disorder","volume":"43","author":"Hill","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0021","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/ajad.12829","article-title":"Drug use and hazardous drinking are associated with PTSD symptoms and symptom clusters in US Army Reserve\/National Guard Soldiers","volume":"28","author":"Homish","year":"2019","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0022","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.psyneuen.2014.11.002","article-title":"The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: a preliminary randomized, double-blind, placebo-controlled cross-over design study","volume":"51","author":"Jetly","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0023","first-page":"4","article-title":"Posttraumatic stress disorder: the burden to the individual and to society","volume":"61","author":"Kessler","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0024","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ejp.1147","article-title":"Availability and approval of cannabis-based medicines for chronic pain management and palliative\/supportive care in Europe: a survey of the status in the chapters of the European Pain Federation","volume":"22","author":"Krcevski-Skvarc","year":"2018","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0025","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.biopsych.2017.03.007","article-title":"It is time to address the crisis in the pharmacotherapy of posttraumatic stress disorder: a consensus statement of the PTSD Psychopharmacology working group","volume":"82","author":"Krystal","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0026","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/da.22511","article-title":"Psychotherapy versus pharmacotherapy for posttraumatic stress disorder: systemic review and meta\u2010analyses to determine first\u2010line treatments","volume":"33","author":"Lee","year":"2016","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0027","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ehb.2016.09.005","article-title":"The effect of military deployment on mental health","volume":"23","author":"Lyk-Jensen","year":"2016","journal-title":"Econ. Hum. Biol."},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0028","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.2174\/138161212802884780","article-title":"Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers","volume":"18","author":"Martin-Santos","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0029","first-page":"124","article-title":"Cannabinoid interventions for PTSD: where to next?","volume":"93","author":"Ney","year":"2019"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0042","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.neuropharm.2011.02.029","article-title":"Treating nightmares and insomnia in posttraumatic stress disorder: A review of current evidence","volume":"62","author":"Nappi","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0030","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/dta.1377","article-title":"Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence","volume":"4","author":"Passie","year":"2012","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0031","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00213-006-0508-y","article-title":"The acute effects of cannabinoids on memory in humans: a review","volume":"188","author":"Ranganathan","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0032","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/S0924-977X(12)70563-1","article-title":"Post-traumatic stress disorder and medical cannabis use: a naturalistic observational study","volume":"22","author":"Reznik","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0033","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40261-014-0212-3","article-title":"Preliminary, open-label, pilot study of add-on oral \u03949-tetrahydrocannabinol in chronic post-traumatic stress disorder","volume":"34","author":"Roitman","year":"2014","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0034","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1056\/NEJMra1612499","article-title":"Post-traumatic stress disorder","volume":"376","author":"Shalev","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0035","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/da.22596","article-title":"Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: a literature review: Steenkamp et al","volume":"34","author":"Steenkamp","year":"2017","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0036","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/jama.2015.8370","article-title":"Psychotherapy for military-related PTSD: a review of randomized clinical trials","volume":"314","author":"Steenkamp","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0037","series-title":"Behavioral Neurobiology of PTSD","author":"Vermetten","year":"2018"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0038","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","article-title":"A new taxonomy for describing and defining adherence to medications: New taxonomy for adherence to medications","volume":"73","author":"Vrijens","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0039","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.4088\/JCP.14m09475","article-title":"Marijuana use is associated with worse outcomes in symptom severity and violent behavior in patients with posttraumatic stress disorder","author":"Wilkinson","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120270","article-title":"A meta-analysis of risk factors for combat-related PTSD among military personnel and veterans","volume":"10","author":"Xue","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.euroneuro.2020.04.009_bib0041","first-page":"057","article-title":"Post-traumatic stress disorder","volume":"15","author":"Yehuda","year":"2015","journal-title":"Nat. Rev. Dis. Primer"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20301280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20301280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:56:29Z","timestamp":1760378189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X20301280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":43,"alternative-id":["S0924977X20301280"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.04.009","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experiences with medical cannabis in the treatment of veterans with PTSD: Results from a focus group discussion","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}